NCT01111318View on ClinicalTrials.gov

Pharmacokinetics of Empagliflozin (BI 10773) in Patients With Impaired Liver Function

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

July 31, 2010

Primary Completion Date

November 30, 2010

Conditions
Hepatic InsufficiencyHealthy
Interventions
DRUG

BI 10773

2 tablets BI 10773 25 mg single dose

Trial Locations (1)

Unknown

1245.13.40001 Boehringer Ingelheim Investigational Site, Timișoara

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY